在儿童中成功通过肠道注射粉碎的波萨可纳延迟释放片
Laura L Bio1, Lyndsie Hiroshima1, Hayden T Schwenk2
1Department of Pharmacy, Lucile Packard Children's Hospital Stanford, Palo Alto, California, USA.
Pediatric blood & cancer
|November 22, 2023
概括
粉碎的波萨康纳延缓释放片 (POS-DRT) 为儿科患者提供了一个有前途的肠道选择. 这项研究发现,粉碎的POS-DRT在90%的儿科接触中达到目标度,支持其用于抗真菌治疗.
科学领域:
- 药理学 药理学是指药理学的学科.
- 儿科医学 儿科医学
- 传染性疾病 传染性疾病
背景情况:
- 可纳口服悬浮剂的吸收不稳定,需要频繁的剂量和食物摄入.
- 对于无法耐受标准口服的儿科患者,需要使用肠道配方.
- 粉碎的波萨康纳延缓释放片 (POS-DRT) 显示出潜在的潜力,但儿科数据有限.
研究的目的:
- 评估粉碎POS-DRT作为儿科患者肠道配方的疗效.
- 为了确定粉碎的POS-DRT是否可以在儿童中达到目标波萨可纳度.
主要方法:
- 对涉及9名儿科患者的10次接触进行了回顾性分析.
- 通过肠道途径给药粉碎的POS-DRT.
- 治疗药物监测波萨可纳度的治疗药物监测.
主要成果:
- 在90%的儿科患者接触中,达到了标度.
- 压碎的POS-DRT证明了在儿科患者群体中成功输送波萨可纳.
- 没有发现与粉碎POS-DRT施用相关的显著不良事件.
结论:
- 粉碎的POS-DRT代表了适用于儿科Posaconazole管理的可行的肠道替代方案.
- 这种配方可以改善儿科抗真菌预防和治疗中的坚持和治疗结果.
- 进一步的研究应该在更大的儿科队伍中证实这些发现.
相关概念视频
Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Drug Delivery: Enteral Route
465
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
465
Routes of Drug Administration: Enteral
3.7K
Medications can be administered through the enteral route using liquids, capsules, or tablets.
Enteral administration involves drug administration via the mouth in two ways: orally or sublingually.
Unlike sublingually drugs, drugs that are taken orally pass through the gastrointestinal (GI) tract and get metabolized by the liver. Once metabolized, the drug is absorbed into the systemic circulation, reaching different body parts via the bloodstream. However, while passing through the stomach,...
Enteral administration involves drug administration via the mouth in two ways: orally or sublingually.
Unlike sublingually drugs, drugs that are taken orally pass through the gastrointestinal (GI) tract and get metabolized by the liver. Once metabolized, the drug is absorbed into the systemic circulation, reaching different body parts via the bloodstream. However, while passing through the stomach,...
3.7K
Prevention of Further Absorption of Poison
830
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
830
Routes of Drug Administration: Parenteral
2.0K
The administration of drugs via parenteral routes allows for direct drug introduction into the systemic circulation, resulting in high bioavailability because the medication bypasses the harsh conditions of the gastrointestinal tract and hepatic metabolism.
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
2.0K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
215
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
215


